These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38182804)

  • 1. An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy.
    Martini A; Wever L; Soeterik TFW; Rakauskas A; Fankhauser CD; Grogg JB; Checcucci E; Amparore D; Haiquel L; Rodriguez-Sanchez L; Ploussard G; Qiang P; Affentranger A; Marquis A; Marra G; Ettala O; Zattoni F; Falagario UG; De Angelis M; Kesch C; Apfelbeck M; Al-Hammouri T; Kretschmer A; Kasivisvanathan V; Preisser F; Lefebvre E; Olivier J; Radtke JP; Carrieri G; Moro FD; Boström P; Jambor I; Gontero P; Chiu PK; John H; Macek P; Porpiglia F; Hermanns T; van den Bergh RCN; van Basten JA; Gandaglia G; Valerio M;
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):520-524. PubMed ID: 38182804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy.
    Soeterik TFW; van Melick HHE; Dijksman LM; Küsters-Vandevelde H; Stomps S; Schoots IG; Biesma DH; Witjes JA; van Basten JA
    Eur Urol Oncol; 2022 Jun; 5(3):328-337. PubMed ID: 32972895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.
    Heetman JG; van der Hoeven EJRJ; Rajwa P; Zattoni F; Kesch C; Shariat S; Dal Moro F; Novara G; La Bombara G; Sattin F; von Ostau N; Pötsch N; Baltzer PAT; Wever L; Van Basten JPA; Van Melick HHE; Van den Bergh RCN; Gandaglia G; Soeterik TFW;
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):492-499. PubMed ID: 37932522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.
    Martini A; Soeterik TFW; Haverdings H; Rahota RG; Checcucci E; De Cillis S; Hermanns T; Fankhauser CD; Afferi L; Moschini M; Mattei A; Kesch C; Heidegger I; Preisser F; Zattoni F; Marquis A; Marra G; Gontero P; Briganti A; Montorsi F; Porpiglia F; Van Basten JP; Van den Bergh RCN; Van Melick HHE; Ploussard G; Gandaglia G; Valerio M
    J Urol; 2022 Feb; 207(2):350-357. PubMed ID: 34547922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy.
    Heetman JG; Soeterik TFW; Wever L; Meyer AR; Nuininga JE; van Soest RJ; van Melick HHE; van Basten JPA; van den Bergh RCN
    World J Urol; 2022 Dec; 40(12):2919-2924. PubMed ID: 36344738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
    Martini A; Gupta A; Lewis SC; Cumarasamy S; Haines KG; Briganti A; Montorsi F; Tewari AK
    BJU Int; 2018 Dec; 122(6):1025-1033. PubMed ID: 29676063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
    Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
    AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extension.
    Sayyid R; Perlis N; Ahmad A; Evans A; Toi A; Horrigan M; Finelli A; Zlotta A; Kulkarni G; Hamilton R; Morash C; Fleshner N
    BJU Int; 2017 Jul; 120(1):76-82. PubMed ID: 27930844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer.
    Xiang JY; Huang XS; Xu JX; Huang RH; Zheng XZ; Xue LM; Liu YL
    Biomed Res Int; 2022; 2022():3203965. PubMed ID: 36082151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
    Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
    Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Can We Identify Extraprostatic Extension (EPE) Before Surgery? The Use of a Preoperative Prostate MRI EPE Scoring System to Assess Postprostatectomy Locally Advanced Prostate Cancer.
    Bansal U; Estevez A; Black J; Williamson T; Kaul S; Crociani C; Sun J; Tsai LL; Mechaber-Di Fiori J; Gershman B; Chang P; Wagner AA
    J Endourol; 2024 May; 38(5):499-504. PubMed ID: 38326749
    [No Abstract]   [Full Text] [Related]  

  • 14. Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study.
    Feng T; Liang Z; Xiao Y; Pan B; Zhou Y; Ma C; Zhou Z; Yan W; Zhu M
    Cancer Med; 2024 Jun; 13(11):e7341. PubMed ID: 38845479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
    Diamand R; Roche JB; Lacetera V; Simone G; Windisch O; Benamran D; Fourcade A; Fournier G; Fiard G; Ploussard G; Roumeguère T; Peltier A; Albisinni S
    World J Urol; 2024 Apr; 42(1):247. PubMed ID: 38647728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nomogram for the prediction of seminal vesicle invasion including multiparametric magnetic resonance imaging.
    Martini A; Gupta A; Cumarasamy S; Lewis SC; Haines KG; Briganti A; Montorsi F; Tewari AK
    Int J Urol; 2019 Apr; 26(4):458-464. PubMed ID: 30659663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.
    Bloom JB; Daneshvar MA; Lebastchi AH; Ahdoot M; Gold SA; Hale G; Mehralivand S; Sanford T; Valera V; Wood BJ; Choyke PL; Merino MJ; Turkbey B; Parnes HL; Pinto PA
    Urol Oncol; 2021 Oct; 39(10):729.e1-729.e6. PubMed ID: 33736975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.
    Ucar T; Gunduz N; Demirci E; Culpan M; Gunel H; Kir G; Atis RG; Yildirim A
    Prostate; 2022 Nov; 82(15):1462-1468. PubMed ID: 35915579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.